Key Players in Thailand Anemia Market | Competitive Landscape 2026

Thailand Anemia Market Overview

According to 6Wresearch, the Thailand anemia market is expanding as clinical focus intensifies on "Antenatal Care" and the management of anemia in chronic kidney disease (CKD) patients. With Thailand's status as a "Super-Aging" society, there is an increased demand for erythropoiesis-stimulating agents (ESAs) and therapies with low gastrointestinal side effects for geriatric care.

Furthermore, the market is benefiting from the "Universal Health Coverage" scheme, which ensures that essential hematinic medications are accessible at the primary care level. The transition from basic ferrous salts to advanced iron-protein complexes and liposomal iron is helping to bridge the gap between clinical efficacy and patient compliance.

Competitive Landscape

The competitive landscape of the Thailand anemia market is defined by a strategic mix of global pharmaceutical innovators and robust local manufacturers. Success in this market is driven by "Authorized Generic" partnerships and the ability to navigate the National List of Essential Medicines (NLEM) to secure government procurement contracts.

Below is a list of leading players operating in the Thailand Anemia Market:

1. Pfizer Inc.

A global leader providing high-trust hematology solutions and supportive treatments for anemia in patients undergoing complex therapeutic regimens.

2. Takeda Pharmaceutical Company Limited

Thailand's prominent partner in CNS and hematology, Takeda supplies advanced iron therapies and specializes in managing malabsorption-related anemia.

3. Mega Lifesciences PCL

A homegrown Thai powerhouse and leader in the "Wellness" segment, known for its extensive range of high-quality iron supplements and prenatal vitamins across Southeast Asia.

4. GSK plc

Supplies a diverse portfolio of essential vitamins and hematinics used in the prevention and primary care management of nutritional anemia in Thailand.

5. Sanofi

A critical provider of therapeutic solutions for chronic disease-related anemia, focusing on integrated care for renal and oncology-related hematology.

6. Siam Pharmaceutical Co., Ltd.

A leading domestic manufacturer providing cost-effective generic hematinics that are essential for Thailand’s public hospital tenders and rural health clinics.

7. Berlin Pharmaceutical Industry Co., Ltd.

One of Thailand's oldest and most respected local firms, focusing on high-equity cardiovascular and hematology medications for the domestic market.

8. Bayer AG

A dominant force in women's healthcare, providing specialized iron-fortified prenatal supplements and treatments for iron deficiency anemia.

9. Otsuka Pharmaceutical Co., Ltd.

Leverages its strong Japanese-Thai partnership to distribute clinical nutrition and specialized medications that address secondary anemia in hospital settings.

10. Amgen Inc.

A biotechnology leader supplying erythropoiesis-stimulating agents (ESAs) critical for Thai patients suffering from chronic kidney disease (CKD).

11. CSL Vifor

The global gold standard for iron deficiency, providing the Thai market with premier intravenous iron products like Ferinject for rapid anemia correction.

12. Abbott Laboratories

Provides advanced diagnostic equipment for blood screening and specialized medical nutrition products to support recovery in anemic patients.

13. Biopharm Chemical Co., Ltd.

A key distributor and manufacturer in Thailand that ensures a stable supply of hematology-related drugs and nutritional supplements to retail pharmacies.